First, he wonders how the Government can“assist patients and patient groups to contact researchers and get them interested in LDN research”and“how to best deal with situations where they arise”.Although, as a research prospect, the issue might not be financially interesting to medical companies, it should at least be interesting from a public health perspective, and the petitioner wants us to ask the Government how we might get around that. For example, an individual MSP...